Four therapeutic approaches have evolved to treat arteriovenous malformations: surgery, radiosurgery, embolization, and conservative treatment. There is a lack of consensus about the choice of ...
Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...
Please provide your email address to receive an email when new articles are posted on . Published findings report that, for vascular access in hemodialysis, the creation of an arteriovenous fistula ...
SOUTH JORDAN, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive 6-month findings from the ...
early-dialysis-av-fistula-graft-surgery In the first few months of hemodialysis, one additional provider visit per month increased the probability of AV fistula or graft surgery by nearly 5%. When ...
The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...
The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...
DURHAM, N.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results